THYSSENKRUPP NUCERA AG & CO. KGAA Financials thyssenkrupp nucera AG & Co. KGaA Deutsche Boerse AG
Equities
NCH2
DE000NCA0001
Construction & Engineering
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.825 EUR | -2.63% |
|
-4.43% | -46.31% |
| 06-13 | Thyssen hydrogen subsidiary expects strong market growth | RE |
| 06-06 | Three newcomers to the MDax - Rational, TUI and Traton move up | RE |
Valuation
| Fiscal Period: September | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 2,346 | 1,225 | - | - |
| Enterprise Value (EV) 1 | 1,583 | 562.1 | 646.5 | 663.1 |
| P/E ratio | 88.4 x | -41.7 x | 55.1 x | 25.5 x |
| Yield | - | - | - | 0.13% |
| Capitalization / Revenue | 3.59 x | 1.37 x | 1.1 x | 0.91 x |
| EV / Revenue | 2.43 x | 0.63 x | 0.58 x | 0.49 x |
| EV / EBITDA | 55.2 x | -13.1 x | 19 x | 9.25 x |
| EV / FCF | -88 x | -4.08 x | -8.87 x | -47.8 x |
| FCF Yield | -1.14% | -24.5% | -11.3% | -2.09% |
| Price to Book | 3.15 x | 1.71 x | 1.7 x | 1.61 x |
| Nbr of stocks (in thousands) | 126,315 | 126,315 | - | - |
| Reference price 2 | 18.57 | 9.695 | 9.695 | 9.695 |
| Announcement Date | 23-12-18 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 652.8 | 891 | 1,112 | 1,347 |
| EBITDA 1 | - | 28.7 | -42.79 | 34.12 | 71.71 |
| EBIT 1 | - | 23.8 | -46.84 | 17.98 | 51.32 |
| Operating Margin | - | 3.65% | -5.26% | 1.62% | 3.81% |
| Earnings before Tax (EBT) 1 | - | 34.4 | -23.18 | 24.56 | 55.73 |
| Net income 1 | 6.038 | 22.5 | -29.09 | 21.76 | 47.37 |
| Net margin | - | 3.45% | -3.27% | 1.96% | 3.52% |
| EPS 2 | - | 0.2100 | -0.2323 | 0.1760 | 0.3801 |
| Free Cash Flow 1 | - | -18 | -137.8 | -72.86 | -13.87 |
| FCF margin | - | -2.76% | -15.46% | -6.55% | -1.03% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.0125 |
| Announcement Date | 23-06-23 | 23-12-18 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: September | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 159.4 | 208.3 | 168 | 376.3 | 241.2 | 248.6 |
| EBITDA 1 | - | - | 0.4 | -9.1 | - | -13.12 | -19.28 |
| EBIT 1 | - | 3.5 | -0.9 | -10.6 | -11.4 | -14.12 | -19.74 |
| Operating Margin | - | 2.2% | -0.43% | -6.31% | -3.03% | -5.85% | -7.94% |
| Earnings before Tax (EBT) | - | 9.1 | 4.9 | -4.5 | - | - | - |
| Net income 1 | 6.1 | 4.3 | 2.8 | -7.2 | -4.4 | -5.684 | -9.587 |
| Net margin | - | 2.7% | 1.34% | -4.29% | -1.17% | -2.36% | -3.86% |
| EPS 2 | - | - | 0.0200 | -0.0600 | - | -0.0625 | -0.1429 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 23-08-28 | 23-12-18 | 24-02-13 | 24-05-15 | 24-05-15 | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 762 | 663 | 578 | 562 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -18 | -138 | -72.9 | -13.9 |
| ROE (net income / shareholders' equity) | - | 4.7% | -3.38% | 2.42% | 5.16% |
| ROA (Net income/ Total Assets) | - | 2.7% | -2.48% | 1.19% | 2.97% |
| Assets 1 | - | 833.3 | 1,175 | 1,826 | 1,597 |
| Book Value Per Share 2 | - | 5.900 | 5.660 | 5.710 | 6.040 |
| Cash Flow per Share 2 | - | -0.1300 | -0.5000 | -0.2800 | 0.5200 |
| Capex 1 | - | 3.8 | 58 | 71.8 | 73.2 |
| Capex / Sales | - | 0.58% | 6.51% | 6.46% | 5.43% |
| Announcement Date | 23-06-23 | 23-12-18 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.695
EUR
Average target price
18.96
EUR
Spread / Average Target
+95.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.82% | 10.6B | |
| +73.54% | 2.13B | |
| +34.27% | 2.11B | |
| -18.46% | 1.62B | |
| +17.27% | 1.07B | |
| -10.02% | 678M | |
| -12.46% | 613M | |
| -38.79% | 586M | |
| +7.64% | 458M |
- Stock Market
- Equities
- NCH2 Stock
- NCH2 Stock
- Financials thyssenkrupp nucera AG & Co. KGaA
